Early and accurate detection of cancer starts here. Exai Bio’s next-generation RNA-based platform delivers actionable insight into cancer biology from a simple blood draw.
Keep scrolling to learn what makes our platform unique
Exai is revolutionizing how we diagnose, treat, and manage cancer.
We are entering an era where biology and technology will fuel the development of next-generation diagnostics. These will radically transform our ability to detect, diagnose, treat, and ultimately cure cancer.
Pat Arensdorf
Founder & Chief Executive Officer
Using our novel RNA biomarkers, we found signals in what appeared to others as noise. With these biomarkers and AI, we have connected the dots, finding actionable clinical insights that weren't possible before.
